High-dose antioxidant supplements (vitamin C, vitamin E, alpha-lipoic acid), which may compound effects
389 In contrast, for patients with nonresectable, advanced, or metastatic ESCC, the POWER trial, a phase III study of cisplatin and 5-fluorouracil with or without the monoclonal antibody panitumumab, was stopped early owing to a lack of efficacy in the panitumumab arm, indicating that EGFR inhibition with panitumumab did not improve survival in this unselected advanced ESCC population
The rationale is that many nutraceuticals could work in synergy: by delivering them simultaneously at the right ratio, one might amplify health benefits or address multiple targets in the body
Published on August 18th, 2025
Immune System Fortification Enhances white blood cell function and boosts the body's natural defense mechanisms